
### [MONDO:0018753](http://purl.obolibrary.org/obo/MONDO_0018753)
**Label:** rare disease with malignant hyperthermia

**Subclasses:** [MONDO:0011163](http://purl.obolibrary.org/obo/MONDO_0011163) (malignant hyperthermia, susceptibility to, 5), [MONDO:0011271](http://purl.obolibrary.org/obo/MONDO_0011271) (rigid spine muscular dystrophy 1), [MONDO:0018546](http://purl.obolibrary.org/obo/MONDO_0018546) (serotonin syndrome), [MONDO:0019951](http://purl.obolibrary.org/obo/MONDO_0019951) (rigid spine syndrome), [MONDO:0018752](http://purl.obolibrary.org/obo/MONDO_0018752) (exercise-induced malignant hyperthermia), [MONDO:0009012](http://purl.obolibrary.org/obo/MONDO_0009012) (multiple pterygium-malignant hyperthermia syndrome), [MONDO:0015794](http://purl.obolibrary.org/obo/MONDO_0015794) (antenatal multiminicore disease with arthrogryposis multiplex congenita), [MONDO:0011164](http://purl.obolibrary.org/obo/MONDO_0011164) (malignant hyperthermia, susceptibility to, 6), [MONDO:0015793](http://purl.obolibrary.org/obo/MONDO_0015793) (moderate multiminicore disease with hand involvement), [MONDO:0020485](http://purl.obolibrary.org/obo/MONDO_0020485) (king-Denborough syndrome), [MONDO:0019398](http://purl.obolibrary.org/obo/MONDO_0019398) (desmin-related myopathy with Mallory body-like inclusions), [MONDO:0018493](http://purl.obolibrary.org/obo/MONDO_0018493) (malignant hyperthermia (disease)), [MONDO:0007939](http://purl.obolibrary.org/obo/MONDO_0007939) (malignant hyperthermia, susceptibility to, 2), [MONDO:0009722](http://purl.obolibrary.org/obo/MONDO_0009722) (Native american myopathy), [MONDO:0009712](http://purl.obolibrary.org/obo/MONDO_0009712) (congenital multicore myopathy with external ophthalmoplegia), [MONDO:0019790](http://purl.obolibrary.org/obo/MONDO_0019790) (neuroleptic malignant syndrome), [MONDO:0007940](http://purl.obolibrary.org/obo/MONDO_0007940) (malignant hyperthermia, susceptibility to, 3), [MONDO:0007783](http://purl.obolibrary.org/obo/MONDO_0007783) (malignant hyperthermia, susceptibility to, 1), [MONDO:0017939](http://purl.obolibrary.org/obo/MONDO_0017939) (classic multiminicore myopathy), [MONDO:0010893](http://purl.obolibrary.org/obo/MONDO_0010893) (malignant hyperthermia, susceptibility to, 4), [MONDO:0018948](http://purl.obolibrary.org/obo/MONDO_0018948) (multiminicore myopathy), 

**Corr. equiv. classes:** [Orphanet:94093](http://www.orpha.net/ORDO/Orphanet_94093), [Orphanet:324604](http://www.orpha.net/ORDO/Orphanet_324604), [OMIM:602771](http://purl.obolibrary.org/obo/OMIM_602771), [OMIM:600467](http://purl.obolibrary.org/obo/OMIM_600467), [OMIM:601887](http://purl.obolibrary.org/obo/OMIM_601887), [OMIM:154275](http://purl.obolibrary.org/obo/OMIM_154275), [OMIM:601888](http://purl.obolibrary.org/obo/OMIM_601888), [OMIM:154276](http://purl.obolibrary.org/obo/OMIM_154276), [Orphanet:84132](http://www.orpha.net/ORDO/Orphanet_84132), [Orphanet:178148](http://www.orpha.net/ORDO/Orphanet_178148), [Orphanet:178145](http://www.orpha.net/ORDO/Orphanet_178145), [Orphanet:43116](http://www.orpha.net/ORDO/Orphanet_43116), [OMIM:255320](http://purl.obolibrary.org/obo/OMIM_255320), [Orphanet:98905](http://www.orpha.net/ORDO/Orphanet_98905), [OMIM:145600](http://purl.obolibrary.org/obo/OMIM_145600), [Orphanet:97244](http://www.orpha.net/ORDO/Orphanet_97244), [Orphanet:466650](http://www.orpha.net/ORDO/Orphanet_466650), [Orphanet:423](http://www.orpha.net/ORDO/Orphanet_423), [OMIM:217150](http://purl.obolibrary.org/obo/OMIM_217150), [OMIM:255995](http://purl.obolibrary.org/obo/OMIM_255995), [Orphanet:99741](http://www.orpha.net/ORDO/Orphanet_99741), [Orphanet:168572](http://www.orpha.net/ORDO/Orphanet_168572), [Orphanet:598](http://www.orpha.net/ORDO/Orphanet_598), [Orphanet:2215](http://www.orpha.net/ORDO/Orphanet_2215), 

**Class expressions from DL-Learner:**

- [HP:0002047](http://purl.obolibrary.org/obo/HP_0002047) (Malignant hyperthermia) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) 44.12%
- [HP:0002047](http://purl.obolibrary.org/obo/HP_0002047) (Malignant hyperthermia) and (not ([HP:0012252](http://purl.obolibrary.org/obo/HP_0012252) (Abnormal respiratory system morphology))) 44.12%
- [HP:0002047](http://purl.obolibrary.org/obo/HP_0002047) (Malignant hyperthermia) and (not ([HP:0000708](http://purl.obolibrary.org/obo/HP_0000708) (Behavioral abnormality))) 44.12%
- [HP:0002047](http://purl.obolibrary.org/obo/HP_0002047) (Malignant hyperthermia) and [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) 41.37%
- [HP:0002047](http://purl.obolibrary.org/obo/HP_0002047) (Malignant hyperthermia) 39.23%
- [HP:0002047](http://purl.obolibrary.org/obo/HP_0002047) (Malignant hyperthermia) and (not ([HP:0000026](http://purl.obolibrary.org/obo/HP_0000026) (Male hypogonadism))) 39.23%
- [HP:0002047](http://purl.obolibrary.org/obo/HP_0002047) (Malignant hyperthermia) and (not ([HP:0000024](http://purl.obolibrary.org/obo/HP_0000024) (Prostatitis))) 39.23%
- [HP:0002047](http://purl.obolibrary.org/obo/HP_0002047) (Malignant hyperthermia) and (not ([HP:0000021](http://purl.obolibrary.org/obo/HP_0000021) (Megacystis))) 39.23%
- [HP:0002047](http://purl.obolibrary.org/obo/HP_0002047) (Malignant hyperthermia) and (not ([HP:0000019](http://purl.obolibrary.org/obo/HP_0000019) (Urinary hesitancy))) 39.23%
- [HP:0002047](http://purl.obolibrary.org/obo/HP_0002047) (Malignant hyperthermia) and (not ([HP:0000018](http://purl.obolibrary.org/obo/HP_0000018) (null))) 39.23%
- [HP:0002047](http://purl.obolibrary.org/obo/HP_0002047) (Malignant hyperthermia) and (not ([HP:0000017](http://purl.obolibrary.org/obo/HP_0000017) (Nocturia))) 39.23%
- [HP:0002047](http://purl.obolibrary.org/obo/HP_0002047) (Malignant hyperthermia) and (not ([HP:0000016](http://purl.obolibrary.org/obo/HP_0000016) (Urinary retention))) 39.23%
- [HP:0002047](http://purl.obolibrary.org/obo/HP_0002047) (Malignant hyperthermia) and (not ([HP:0000013](http://purl.obolibrary.org/obo/HP_0000013) (Hypoplasia of the uterus))) 39.23%
- [HP:0002047](http://purl.obolibrary.org/obo/HP_0002047) (Malignant hyperthermia) and (not ([HP:0000012](http://purl.obolibrary.org/obo/HP_0000012) (Urinary urgency))) 39.23%
- [HP:0002047](http://purl.obolibrary.org/obo/HP_0002047) (Malignant hyperthermia) and (not ([HP:0000011](http://purl.obolibrary.org/obo/HP_0000011) (Neurogenic bladder))) 39.23%


